ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "leukocytopenia,"

  • Abstract Number: 1963 • 2019 ACR/ARP Annual Meeting

    Combining Clinical and Candidate Gene Data into a Risk Score for Azathioprine-Associated Leukopenia in Routine Clinical Practice

    Prathima Anandi 1, Alyson Dickson 2, Qiping Feng 1, Wei-Qi Wei 2, William Dupont 2, Dale Plummer 2, Ge Liu 1, Katherine Barker 2, Vivian Kawai 2, Kelly Birdwell 2, Nancy Cox 1, C. Michael Stein 2, Adriana Hung 2 and Cecilia Chung3, 1Vanderbilt University Medical Center, Nashville, 2Vanderbilt University Medical Center, Nashville, TN, 3Vanderbilt University, Nashville, TN

    Background/Purpose: Azathioprine is a widely-used drug for the treatment of rheumatic diseases, inflammatory bowel disease, and for organ transplantation. However, treatment is often limited by…
  • Abstract Number: 515 • 2017 ACR/ARHP Annual Meeting

    Leukopenia and Tumor Necrosis Factor Alpha Inhibitor Therapy

    Wenlu Xiong1, Rochella A. Ostrowski2, William Adams3 and Rodney Tehrani4, 1Rheumatology, Vanderbilt University Medical Center, Nashville, TN, 2Rheumatology, Loyola University Medical Center, Maywood, IL, 3Clinical Research Office, Loyola University Medical Center, Maywood, IL, 4Rheumatology & Immunology, Loyola University Medical Center, Maywood, IL

    -      Background/Purpose:  Tumor necrosis factor (TNF) alpha, a key proinflammatory cytokine in rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), has been a major target in…
  • Abstract Number: 1629 • 2017 ACR/ARHP Annual Meeting

    Disease Activity Is an Independent Predictor of Leukopenia in a Large International SLE Cohort

    Rangi Kandane-Rathnayake1, Vera Golder2, Worawit Louthrenoo3, Sargunan Sockalingam4, Aisha Lateef5, Yuan An6, Leonid Zamora7, Yeong-Jian Wu8, Shue-Fen Luo9, Madelynn Chan10, Fiona Goldblatt11, Chak Sing Lau12, Zhan-Guo Li13, Sandra V. Navarra7, Mandana Nikpour14, Eric F Morand15 and Alberta Y. Hoi2, 1Rheumatology, Monash University, Melbourne, Australia, 2Centre for Inflammatory Diseases, Monash University, Melbourne, Australia, 3Division of Rheumatology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand, 4University of Malaya, Kuala Lumpur, Malaysia, 5Medicine, Division of Rheumatology, National University Hospital of Singapore, Singapore, Singapore, 6Peking University People's Hospital, Beijing, China, 7Rheumatology, University of Santo Tomas Hospital, Manila, Philippines, 8Chang Gung University, Taoyuan County, Taiwan, 9Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 10Tan Tock Seng Hospital, Singapore, Singapore, 11Flinders University, Adelaide, Australia, 12Univ Dept of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong, 13Peking University International Hospital, Beijing, China, 14Melbourne University, Melbourne, Australia, 15Monash University, Melbourne, Australia

    Background/Purpose: Leukopenia is commonly seen in SLE, but its predictors are not well understood, as it can be a result of disease activity or bone…
  • Abstract Number: 2381 • 2017 ACR/ARHP Annual Meeting

    Hematologic Abnormalities during the Use of Low Dose Methotrexate for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Kathleen Vanni1, Zhi Zhang1, Cassandra Corrigan2 and Daniel H. Solomon3, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Methotrexate (MTX) is known to increase the risk of cytopenias, but the prevalence of hematologic abnormalities among patients taking low dose MTX is poorly…
  • Abstract Number: 2183 • 2012 ACR/ARHP Annual Meeting

    Common Features in Lymphoproliferative Complications in the Course of Primary Sjögren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients

    Luca Quartuccio1, Chiara Baldini2, Roberta Priori3, Elena Bartoloni Bocci4, Francesco Carubbi5, Miriam Isola6, Marta Maset7, Sara Salvin7, Nicoletta Luciano2, Giovanna Picarelli8, Alessia Alunno9, Roberto Giacomelli10, Roberto Gerli11, Guido Valesini12, Stefano Bombardieri13 and Salvatore De Vita1, 1Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy, 2University of Pisa, Rheumatology Unit, Pisa, Italy, 3Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, 4Rheumatology Unit, Department of Clinical & Experimental Medicine, University of Perugia, Perugia, Italy, 5Rheumatology Clinic, University of L'Aquila, L'Aquila, Italy, 6Institute of Statistics, University of Udine, Udine, Italy, 7Rheumatology Clinic, DSMB, University of Udine, Italy, Udine, Italy, 8Rheumatology Unit, Sapienza University of Rome, Rome, Italy, 9Clinical and Experimental Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 10Rheumatology Unit, University of Aquila, L'Aquila, Italy, 11Rheumatology Unit, University of Perugia, Perugia, Italy, 12Clinica e Terapia Medica, Sapienza, Universita di Roma, Rome, Italy, 13Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy

    Background/Purpose: To describe the prevalence of lymphoproliferative complications (defined as B-cell lymphoma or definite conditions predisposing to lymphoma, i.e,  cryoglobulinemic vasculitis (CV) and major salivary…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.